|
Report No. : |
323241 |
|
Report Date : |
18.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
HINO PHARMACEUTICALCO LTD |
|
|
|
|
Registered Office : |
2-3-15 Doshomachi Chuoku Osaka 541-0045 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.03.2015 |
|
|
|
|
Date of Incorporation : |
July 1947 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Subject is manufacturer of raw incense materials, medical raw materials, spices, foods, cosmetics |
|
|
|
|
No. of Employee : |
20 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
JAPAN - ECONOMIC OVERVIEW
In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Since the complete shutdown of Japan’s nuclear reactors after the earthquake and tsunami disaster in 2011, Japan's industrial sector has become heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession four times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. A sales tax increase caused the economy to contract during the 2nd and 3rd quarters of 2014. The economy has largely recovered in the three years since the disaster, but reconstruction in the Tohoku region has been uneven due to labor shortages. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2014 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which amounts to more than 240% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by 2015, although the government in 2014 decided to postpone the final phase of the increase until 2017 to give the economy time to recover from the 2014 increase. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy.
|
Source
: CIA |
HINO PHARMACEUTICALCO LTD
REGD NAME: Hino
Yakuhin KK
MAIN OFFICE: 2-3-15
Doshomachi Chuoku Osaka 541-0045 JAPAN
Tel:
06-6231-5847 Fax: 06-6231-2309
URL: http://www.hinopharma.co.jp
E-Mail
address: hino@hinopharma.co.jp
Mfg of
raw incense materials, medical raw materials, spices, foods, cosmetics
Osaka
(Chinese tea shops, acupuncture clinic)
Okayama
TAKASHI
HINO, PRES
Toshihiro
Katsuma, dir
Kazue Hamada, dir
Yen
Amount: In million Yen, unless
otherwise stated
FINANCES FAIR A/SALES Yen
1,300 M
PAYMENTS NO COMPLAINTS CAPITAL Yen 15
M
TREND SLOW WORTH Yen
405 M
STARTED 1947 EMPLOYES 20
MFR OF INCENSE AND PHARMACEUTICAL RAW MATERIALS.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY
BUSINESS ENGAGEMENTS.
The subject company was established by father of Takashi
Hino in order to make most of his experience in the subject line of
business. This is a specialized mfr of
raw materials for incense, medical & pharmaceuticals (including Chinese
medicines), spices, cosmetics, foods, health foods, other. Also operates Chinese tea shops, acupuncture
& moxibustion clinic in Osaka. Raw
materials are imported from China (Chinese drugs), S/E Asia, USA, Europe,
Africa, Mid/Near East countries, other.
Agents for Naqi NV. SA (Belgium) and Elizabeth Van Bureau Inc
(USA). Clients include pharmaceutical
mfrs nationwide.
Financials
are only partially disclosed
The sales volume for Mar/2014 fiscal term amounted to Yen
1,300 million, a 2% down from Yen 1,330 million in the previous term. The net profit was posted at Yen 18 million,
compared with Yen 20 million a year ago.
For the term that ended Mar 2015 the net profit is projected
at Yen 20 million, on a 5% rise in turnover, to Yen 1,360 million. Final results are yet to be released.
The financial situation is considered FAIR and good for
ORDINARY business engagements.
Date
Registered: July
1947
Legal
Status: Limited
Company (Kabushiki Kaisha)
Authorized: 120,000
shares
Issued:
30,000 shares
Sum:
Yen 15
million
Major shareholders (%):
Takashi Hino (100)
Nothing detrimental is known as to
the commercial morality of executives.
Activities: Manufactures raw materials for
incense, Chinese drugs, medical pharmaceuticals, cosmetics, spices, foodstuffs,
health foods, other; operates Chinese tea shops and acupuncture &
moxibustion clinic in Osaka, others (--100%)
Clients: [Mfrs, wholesalers, consumers] Kotaro
Pharmaceutical Co, Rohto Pharmaceutical Co, Morishita Jintan Co, Ohta Isan Co,
Hitifuku Inc, other
No. of accounts: 500
Domestic areas of activities:
Nationwide
Suppliers: [Mfrs, wholesalers] Raw materials are
imported from: China, S/E Asia, Europe, India, Brazil, Africa, Belgium, other.
Import agent for: Naqi NV. SA
(Belgium), and Elizabeth Van Bureau Inc (USA)
Payment record: No Complaints
Location:
Business area in Osaka. Office premises
at the caption address are owned and maintained satisfactory.
Bank
References:
MUFG (Kawaramachi)
Hokuriku Bank (Osaka)
Relations: Satisfactory
(In Million Yen)
|
Terms Ending: |
|
31/03/2015 |
31/03/2014 |
31/03/2013 |
31/03/2012 |
|
Annual
Sales |
|
1,360 |
1,300 |
1,330 |
1,340 |
|
Recur.
Profit |
|
.. |
.. |
.. |
.. |
|
Net
Profit |
|
20 |
18 |
20 |
20 |
|
Total
Assets |
|
|
N/A |
N/A |
N/A |
|
Net
Worth |
|
|
405 |
390 |
370 |
|
Capital,
Paid-Up |
|
|
15 |
15 |
15 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
4.62 |
-2.26 |
-0.75 |
0.00 |
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
|
.. |
.. |
.. |
|
N.Profit/Sales |
|
1.47 |
1.38 |
1.50 |
1.49 |
Notes:
Financials are only partially disclosed.
Forecast
(or estimated) figures for the 31/03/2015 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.58 |
|
|
1 |
Rs.100.30 |
|
Euro |
1 |
Rs.72.38 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.